Skip to main content
. Author manuscript; available in PMC: 2014 Sep 5.
Published in final edited form as: Am J Infect Control. 2011 Jul 27;40(4):349–353. doi: 10.1016/j.ajic.2011.04.002

Table 2.

Treatment and outcome of the patients during the two periods [(Period A (between 1/4/09 and 4/3/09), Period B (between 5/21/09 and 8/17/09)]

Period A
(n=1221)
n (%)
Period B
(n=1160)
n (%)
p value

Outcomes

Discharge Disposition
 Home 777 (63.6) 739 (64.1) Ref
 Long Term Care 314 (25.7) 297 (25.6) 0.95
 Hospice/Expired 125 (10.3) 117 (10.1) 0.90

Colectomy for CDI 0 (0) 0 (0) -

Readmission within 30 Days 316 (25.9) 291 (25.1) 0.66

Length of stay after first negative
[days, median (range)]
5 (0, 119) 5 (0, 83) 0.07

Patients with more than 1 test 498 (40.8) 548 (47.2) < 0.01

Number of repeated tests 1[median
(range)]
2 (1-15) 2 (1-15) 0.57

Treatments

Metronidazole
 Before First Test 160 (13.1) 165 (14.2) 0.43
 After First Test 2 504 (41.3) 414 (35.7) <0.01

Oral Vancomycin
 Before First Test 35 (2.9) 22 (1.9) 0.12
 After First Test 2 185 (15.2) 85 (7.3) <0.01

Anti-diarrheals
 Before First Test 155 (12.7) 167 (14.4) 0.23
 After First Test 2 267 (21.9) 312 (26.9) <0.01
1

In patients who had a test repeated after an initial negative test

2

Regardless of test results